IBEX CEO sells 7,800 shares in open-market trade

IBEX Ltd Chief Executive Officer Robert Thomas Dechant sold 7,800 common shares in an open-market transaction.

Rhea-AI Filing Summary

IBEX Ltd Chief Executive Officer Robert Thomas Dechant sold 7,800 common shares in an open-market transaction. The shares were sold at a weighted average price of $30.4996 per share, with individual trades executed between $30.37 and $30.88. After this sale, Dechant directly holds 285,606 IBEX common shares.

Insider Trade Summary

Net Seller: 7,800 shares

Net Sell 1 txn

Insider Dechant Robert Thomas

Role Chief Executive Officer

Sold 7,800 shs ($238K)

Type	Security	Shares	Price	Value
Sale	Common Shares	7,800	$30.4996	$238K

Holdings After Transaction: Common Shares — 285,606 shares (Direct)

Footnotes (1)

1. F1. This transaction was executed in multiple trades at prices ranging from $30.37 to $30.88; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold: 7,800 shares Weighted average sale price: $30.4996 per share Post-transaction holdings: 285,606 shares +1 more

4 metrics

Shares sold 7,800 shares Open-market sale of IBEX common shares

Weighted average sale price $30.4996 per share Price for 7,800 IBEX common shares sold

Post-transaction holdings 285,606 shares IBEX common shares held directly after sale

Trade price range $30.37–$30.88 per share Range of prices for individual trades in the sale

Key Terms

open-market sale, weighted average sales price, Form 4, beneficially owned

4 terms

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

weighted average sales price financial

"the price reported above reflects the weighted average sales price"

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

beneficially owned financial

"total_shares_following_transaction": "285606.0000""

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IBEX (IBEX) report on this Form 4?

IBEX reported that CEO Robert Thomas Dechant sold 7,800 common shares in an open-market transaction. The sale was executed at a weighted average price of $30.4996 per share, with multiple trades within a disclosed price range.

What price did the IBEX CEO receive for the 7,800 shares sold?

The IBEX CEO received a weighted average price of $30.4996 per share for the 7,800 common shares sold. Individual trades occurred at prices ranging from $30.37 to $30.88, according to the Form 4 footnote.

How many IBEX shares does CEO Robert Dechant hold after this sale?

After the reported sale, CEO Robert Thomas Dechant directly holds 285,606 IBEX common shares. This post-transaction holding figure is disclosed in the Form 4 as the total shares beneficially owned following the transaction.

Was the IBEX CEO’s sale an open-market transaction?

Yes, the Form 4 identifies the transaction as an open-market sale of IBEX common shares. The filing notes multiple trades executed between $30.37 and $30.88 per share, with a reported weighted average sales price for the shares sold.

Does the IBEX Form 4 disclose a price range for the CEO’s share sale?

Yes. The Form 4 footnote states that the CEO’s sale was executed in multiple trades at prices ranging from $30.37 to $30.88 per share, and that the weighted average sales price reported is $30.4996.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 05:04 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dechant Robert Thomas

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DISTRICT OF COLUMBIA 20006

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	05/13/2026		S		7,800	D	$30.4996(1)	285,606	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $30.37 to $30.88; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)